Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

XDR-TB patient Hanif, taking his daily TB medication at home in the Govandi area of Mumbai, 2016. Photograph by Atul Loke
Press release
Press release |
17 August 2018
Tuberculosis

MSF applauds the World Health Organization’s move to recommend improved tuberculosis treatment options

5 min
First set of free Hepatitis C medicines Sofosbuvir and Daclatasvir provided by Delhi Govt. run GB Pant hospital. Photograph by Garvit Nangia Photograph by Garvit Nangia
Press release
Press release |
16 August 2018
Hepatitis C
China

Gilead loses monopoly control of its blockbuster hepatitis C medicine in China

3 min
MSF TB-MDR patients and Green House photos in Mathare. Photograph by Matthias Steinbach
Press release
Press release |
27 July 2018
Tuberculosis

Update on contentious negotiations for the UN High-level Meeting on Tuberculosis

3 min
Patients and MSF staff perform a dance to welcome new members to the "six-months-meeting day" in Mbulumbuzi Health Centre for the Adolescent HIV project in Malawi, it also monitors all the girls and boy who have already joined the program. Photograph by Luca Sola
Press release
Press release |
23 July 2018
HIV/AIDS
KenyaMalawiNigeriaSouth Africa

Pfizer and GSK’s HIV/AIDS division, ViiV, prevents children with HIV from getting needed medicine

4 min
MSF TB-MDR patients and Green House photos in Mathare, Kenya, 2014. Photograph by Matthias Steinbach
Press release
Press release |
20 July 2018
Tuberculosis
United States of America

At last minute, countries pressured to drop language on protecting access to affordable medicines from TB Summit declaration negotiations

3 min
Civil society demonstration against IP provisions in RCEP that can block access to affordable medicines. Outside Ministry of Commerce, Udyog Bhawan, New Delhi Photograph by Siddharth Singh
Press release
Press release |
20 July 2018
Intellectual property and trade

ASEAN and India urged not to trade away people’s lives in trade agreement

3 min
  Sinethemba, 16 years,her MSF counsellor, Xoliswa, at her home in Khayelitsha, Western Cape, South Africa, where she lives with her grandmother, Vuyisiwa Madubela, and four other familtb_southafrica_sinethembawithcounselor_msf177617_sydellwillowsmith.jpg Photograph by Sydelle Willow Smith
Press release
Press release |
03 July 2018
Tuberculosis
RwandaSouth Africa

South Africa and Rwanda’s leaders commit to attend September UN TB Summit

People affected with Hepatitis C and HIV protesting at Delhi Patent Office during hearing of Sofosbuvir Patent Opposition, February 2016 Photograph by Siddharth Singh
Press release
Press release |
19 June 2018
Hepatitis C
China

MSF challenges Gilead’s unmerited patent in China for lifesaving hepatitis C medicine

4 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury